Eledon Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance, Current
Eledon Pharmaceuticals, Inc. (ELDN) had Deferred Tax Assets, Net of Valuation Allowance, Current of $414.00 thousand as of 2014-12-31, per its 10-K filed 2015-03-26.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2015-03-26
- 2014-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $414.00K.
- 2013-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $201.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2014-12-31 | $414.00K 10-K · filed 2015-03-26 |
| 2013-12-31 | $201.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |